HPV Vaccines

AIDS 2014: Young People with HIV Respond Well to Human Papillomavirus Vaccine

The quadrivalent human papillomavirus (HPV) vaccine worked as well for teens and young adults with HIV as it did for their HIV negative counterparts, according to study findings presented the 20thInternational AIDS Conference last week in Melbourne.

alt

Read more:

Human Papillomavirus Vaccine Is Effective for Women with HIV

HIV positive women respond well to the Gardasil human papillomavirus (HPV) vaccine, offering them protection against cervical cancer, according to a study published in the April 14 electronic edition of Clinical Infectious Diseases. Related recent research found that both Gardasil and Cervarix are effective in people with HIV.

alt

Read more:

IDWeek 2013: HIV+ Young Women Have Adequate Response to Human Papillomavirus Vaccine

HIV positive girls did not respond as well to the quadrivalent human papillomavirus (HPV) vaccine as HIV negative girls of the same age, but they responded as well as HIV negative older women, probably giving them sufficient protection from infection, according to a late-breaker presentation at the recent IDWeek conference in San Francisco.

alt

Read more:

Black Women More Likely to Carry Human Papillomavirus Strains Not Covered by Vaccines

African-American women with precancerous cervical abnormalities are about half as likely to have cancer-causing human papillomavirus (HPV) types 16 and 18, and more likely to have other types for which the Gardasil and Cervarix vaccines do not provide protection, according to a study presented at the American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research taking pace this week in Maryland.

alt

Read more:

IDWeek 2013: Low-income Girls Are Less Likely to Receive Full HPV Vaccine Series

altLow-income adolescents are not as likely to start or finish the 3-shot human papillomavirus (HPV) vaccine series, which reduces the risk of cervical cancer. Cultural differences can help explain some of the reasons for this disparity and suggest targeted approaches for encouraging vaccination, researchers reported at Second IDWeek conference this week in San Francisco.

Read more: